European Pharmaceutical Review

AUGUST 7, 2025

The AI Act substantially raises the compliance bar for pharmaceutical companies using AI, particularly in high-risk applications. 2 This publication represents a critical step toward providing operational clarity and practical direction for pharmaceutical companies navigating this challenging regulatory environment.

Pharmaceutical Companies

Express Pharma

JANUARY 15, 2025

Alembic Pharmaceuticals announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Brexpiprazole Tablets, 0.25 mg, 1 mg, 2 mg, 3 mg and 4 mg, of Otsuka Pharmaceutical Company, Ltd. mg, 1 mg, 2 mg, 3 mg and 4 mg. Brexpiprazole Tablets, 0.25

Pharmaceutical Companies

Express Pharma

NOVEMBER 28, 2024

Between September and October 2024, EY-P and OPPI undertook primary research * consulting top CXOs from leading Indian and global multinational pharmaceutical companies, to understand their perspective on the pivotal growth areas for the Indian pharma industry.

Pharmaceutical Manufacturing

Express Pharma

DECEMBER 15, 2024

The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. Teachers and postgraduate and PhD students specialising in Pharmaceutics and Pharmaceutical Analysis also participated.

Pharmaceutical Manufacturing

Express Pharma

JANUARY 13, 2025

Improving productivity is also vital as it aligns with the broader trend of AI adoption across industries, which is also pushing pharmaceutical companies to integrate advanced technologies to remain competitive and keep up with digitalisation trends.

Pharmaceutical Companies

Express Pharma

FEBRUARY 7, 2025

Ind-Ra has maintained a Stable rating Outlook on 67 per cent of its rated pharmaceutical companies in FY25, citing a low leverage ratio and adequate liquidity, and expects limited rating movements in the sector. Most large pharmaceutical companies rated by Ind-Ra fall into high investment-grade categories.

Pharmaceutical Companies

Express Pharma

NOVEMBER 10, 2024

Lupin, a global pharmaceutical company, has announced its tentative approval from the United States Food and Drug Administration (U.S. according to IQVIA data for the 12 months ending September 2024. FDA) for its Abbreviated New Drug Application for Raltegravir Tablets USP, 600 mg. The post Lupin receives tentative U.S.

Immunization

Express Pharma

DECEMBER 30, 2024

On December 29, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 12 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on Complaints and Product Recall. The session provided clarity on the guidelines and cleared the queries of the pharma professionals.

Documentation

Pharmaceutical Technology

JUNE 19, 2025

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) indications witnessed a 339% ($2.17bn) increase in total licensing agreement deal value from 2023 to 2024, reaching a total deal value of $2.81bn, according to GlobalData’s Pharma Intelligence Center Deals Database. ASOs accounted for more than half ($3.54

Communication

Express Pharma

APRIL 8, 2025

In 2023, the company enhanced its Glenview, Illinois facility to meet the rising market need for fluid management systems and virus filtration technologies. In 2024, it completed a new Planova assembly plant in Nobeoka, Miyazaki, Japan, to ensure consistent global supply.

Pharmaceutical Manufacturing

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Pharmaceutical Commerce

JUNE 17, 2025

Structuring patient assistance programs as independent non-profit foundations helps pharmaceutical companies reduce regulatory and legal exposure while allowing for more holistic, patient-centered support. Lastly, PAPs that are directly managed by pharmaceutical companies may also struggle with public image issues.

Pharmaceutical Companies

PharmaVoice

JULY 14, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Q&A Need a DTC platform?

Pharmaceutical Companies

Pharma Marketing Network

JULY 26, 2025

For starters, trust in pharmaceutical companies remains fragile. According to Edelman’s 2024 Trust Barometer, the healthcare sector saw only modest improvements in public trust. Even large pharmaceutical companies sometimes struggle to extract value from their tech stack.

HIPAA

Pharmaceutical Technology

JUNE 24, 2025

This rapid processing not only enhances throughput, but will also allow pharmaceutical companies to respond more swiftly to market demands. DMC’s innovative design incorporates an ultrathin conductive layer, typically made of gold, which enables the application of electrical fields across ionic and affinity membrane adsorbers.

Pharmaceutical Manufacturing

European Pharmaceutical Review

NOVEMBER 25, 2024

percent between 2024 and 2032. An increasing trend of outsourcing boosts growth of the market as pharmaceutical companies are utilising advanced testing capabilities and optimising their drug development processes. percent market share between 2024 and 2032, based on the forecast by Straits Research. billion by 2032.

Drug Development

PharmExec

JULY 31, 2025

in 2024, is projected to reach over $58B by 2033. But it is also a mindset shift that sees complexity as a therapeutic advantage rather than something too complex to standardize. This entry comes at a time when patient demand is accelerating. The global botanical drug market, valued at $37.5B In the U.S.,

Drug Development

Express Pharma

JUNE 19, 2025

By 2024, more than 750 Indian facilities were registered with the U.S. Indian pharmaceutical companies supply more than 60 per cent of global demand for vaccines and over 40 per cent of generic medicines consumed in the United States (2). In FY 2024–25, India’s pharmaceutical exports exceeded USD 30.3

Documentation

European Pharmaceutical Review

JANUARY 22, 2025

Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceutical company. This data was presented at the 2024 American Society of Psychopharmacology Annual Meeting (Poster W80). At week 4, 22.5

Pharmaceutical Companies

European Pharmaceutical Review

NOVEMBER 1, 2024

The worldwide pharmaceutical container packaging market is expected to rise in revenue from $104.12 percent between 2024 and 2033. As pharmaceutical companies are making investments in sustainable packaging this is also driving demand in this market, based on analysis of the study’s findings.

Packaging

Express Pharma

APRIL 7, 2025

Additionally, pharmaceutical companies have increasingly turned to FDCs as a way to differentiate their products in a highly competitive market. By introducing unique formulations that combine existing drugs, companies can extend product life cycles and maintain exclusivity over certain combinations.

Generic Medicine

Pharmaceutical Commerce

JUNE 17, 2025

Bridging the Gap Between Strategy and Practice in IDN Partnerships Partha Anbil ; Kamini Anbil June 9th 2025 Article In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional sales models to strategic, measurable partnerships with integrated delivery networks (IDNs).

Insurance Coverage and Processing

Pharmacy Times

JUNE 24, 2025

This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen Pharmaceutical Companies), and lenalidomide. Updated April 2, 2024. 2 We’re still trying to figure out where these new treatments best fit.

Pharmacy Technician

Big Molecule Watch

JULY 29, 2025

Harrow is a North American pharmaceutical company that specializes in ophthalmologic products including topical antibiotic/corticosteroid combinations, anesthetics, and dry eye disease treatments. Biogen notified Samsung Bioepis of its decision to terminate the agreement within the United States and Canada in October 2024.

Biosimilars

Express Pharma

DECEMBER 24, 2024

The impact of packaging is felt only when it does not do its job and therefore pharmaceutical companies have traditionally invested quite a bit on product packs, also using them as part of their branding strategy. per cent CAGR.

Packaging

Pharmaceutical Commerce

JUNE 18, 2025

Incorporating AI into Commercialization Plans Nicholas Saraceno, Editor September 30th 2024 Podcast Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

Specialty Pharmacies

Express Pharma

FEBRUARY 9, 2025

In October 2024, the programme entered a strategic commercial partnership with Sun Pharma, a leading multinational pharmaceutical company. Dario Neri, CEO of Philogen, stated, We are highly encouraged by the progress of Fibromuns pivotal trials in both soft tissue sarcoma and glioblastoma.

Pharmaceutical Companies

European Pharmaceutical Review

MARCH 27, 2025

As scientific and pharmaceutical companies grapple to secure the worlds best talent, the science and immigration sectors are aware that the UKs ability to attract global talent in science and technology is constantly under question. Summary of visa costs analysis 2024. How do the UKs immigration costs compare? References 1.

Pharmaceutical Companies

pharmaphorum

JULY 24, 2025

Skip to main content Thursday 24 July 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

PharmaTech

JULY 25, 2025

*full transcript below In Part 4 of our multi-part interview series, Jason Waite, an international trade expert at Alston & Bird, underscores the urgent need for pharmaceutical companies to build cross-functional trade compliance teams in response to rising global trade tensions—particularly potential Section 232 tariffs.

Dosage

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmaceutical Commerce

JUNE 9, 2025

Over the past couple years, the demand for this RSV vaccine has continued to be high; in fact, Sanofi had announced in October 2023 that the extraordinary demand had caused shortages impacting the 2023-2024 season. February 2, 2024. 2 The CDC did not revise any recommendations for the 50 mg doses at that time. June 9, 2025.

Drug Pricing

Express Pharma

FEBRUARY 9, 2025

Alkem Laboratories, an Indian pharmaceutical company, has announced two strategic acquisitions aimed at strengthening its position in the domestic market. The company has signed a binding term sheet to acquire a 100 per cent stake in Adroit Biomed, a company focused on the skincare segment, for approximately INR 140 crore.

Pharmaceutical Companies

Pharma Marketing Network

MAY 11, 2025

Since early Q2 2024, Asian pharma stocks have steadily declined, with notable drops in companies heavily reliant on U.S. Market Snapshot Sun Pharmaceutical Industries Ltd. India): Down 11% since March 2024 CSPC Pharmaceutical Group (China): Fell over 14% in April 2024 Takeda Pharmaceutical Co.

Drug Pricing

FDA Law Blog: Biosimilars

JUNE 1, 2025

With regard to influencers, the Federal Trade Commission (FTC) maintains its Endorsement Guides and, in 2021, sent over 700 Notice of Penalty Offenses letters, a number of which were directed toward pharmaceutical companies.

Pharmaceutical Companies

pharmaphorum

JUNE 24, 2025

Skip to main content Tuesday 24 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Pharmaceutical Technology

JULY 18, 2025

Developed by US biotech ARS Pharmaceuticals and under exclusive license in the UK by Danish pharmaceutical company ALK-Abelló, the single-dose nasal spray is indicated for use in adults and children weighing over 30kg and delivers its entire contents (2mg) upon activation. Don’t let policy changes catch you off guard.

Packaging